 | • レポートコード：MRC2303I0128 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の元素分析市場規模が、予測期間中に年平均6.2%で成長すると予測しています。本レポートは、元素分析の世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（有機元素分析、無機元素分析）分析、技術別（破壊技術、非破壊技術、その他）分析、エンドユーザー別（製薬＆バイオテクノロジー企業、研究機関、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などを以下の構成でまとめています。また、Thermo Fisher Scientific, Inc.、PerkinElmer, Inc.、Shimadzu Corporation、Analytik Jena GmbH+Co. KG、Agilent Technologies, Inc.、Elemental Analysis, Inc.、Rigaku Corporation、Eurofins Scientific、Bruker、Verder Scientific GmbH & Co. KG (ELTRA GmbH)、Angstrom Advanced Inc.、HORIBA, Ltdなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の元素分析市場規模：種類別 - 有機元素分析の市場規模 - 無機元素分析の市場規模 ・世界の元素分析市場規模：技術別 - 破壊技術の市場規模 - 非破壊技術の市場規模 - その他技術の市場規模 ・世界の元素分析市場規模：エンドユーザー別 - 製薬＆バイオテクノロジー企業における市場規模 - 研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界の元素分析市場規模：地域別 - 北米の元素分析市場規模 アメリカの元素分析市場規模 カナダの元素分析市場規模 メキシコの元素分析市場規模 … - ヨーロッパの元素分析市場規模 ドイツの元素分析市場規模 イギリスの元素分析市場規模 フランスの元素分析市場規模 … - アジア太平洋の元素分析市場規模 中国の元素分析市場規模 日本の元素分析市場規模 インドの元素分析市場規模 … - 中東/南米の元素分析市場規模 南アフリカの元素分析市場規模 ブラジルの元素分析市場規模 アルゼンチンの元素分析市場規模 … - その他地域の元素分析市場規模 ・競争状況 ・市場機会・将来の動向 |
The elemental analysis market is expected to register a CAGR of 6.2% over the forecast period.
The elemental analysis market was significantly impacted by the COVID-19 pandemic. In the case of COVID-19 patients, there was an abnormal amount of trace elements in the body, and the respiratory system was at risk of infection due to the higher concentrations of heavy metals in the blood. For instance, as per the study report published by the American Journal of Analytical Chemistry in May 2021, the elemental analysis in COVID-19 patients was performed using an atomic absorption (AA) spectrophotometer, which revealed that COVID-19 patients have abnormal levels of essential trace metals (zinc, iron, and copper) versus toxic elements (cadmium and nickel) in the biological samples. As a result of the COVID-19 effect on elements in the bloodstream, the demand for elemental analysis was significant, which drove the market’s growth during the pandemic phase. Currently, the number of COVID-19 cases is relatively low throughout the world; its impact on the market is stable, and the trend is expected to continue due to the ongoing research activities on COVID-19 and emerging viral strains, as per the analysis.
Over the forecast period, the major growth drivers of the elemental analysis market are growing research and development funding in life sciences and mandated government regulations for elemental analysis of pharmaceutical and healthcare products. According to the National Institutes of Health (NIH), Estimates of Funding for Various Research Categories in 2022, it is estimated that the clinical research funding under the life sciences in the United States for 2021 was USD 17,681 million, and it is expected to increase to USD 18,405 million in 2022 and USD 18,383 million in 2023. Thus, the gradual rise in research and development funding is expected to positively impact the market over the forecast period, as elemental analysis is one of the techniques used in clinical research for testing samples of body fluids.
Furthermore, in August 2022, Analytik Jena published that, in a few years, Germany’s legislation will make phosphorus recovery from sewage sludge mandatory. The Analytik Jena PlasmaQuant 9100 ICP-OES instrument detects the included nutrients and essential elements in a single measurement cycle, eliminating the need for time-consuming analysis.
However, a lack of skilled personnel is expected to restrain the elemental analysis market’s growth during the forecast period.
Elemental Analysis Market Trends
Inorganic Elemental Analysis Dominate the Global Elemental Analysis Market During the Forecast Period
Inorganic elemental analysis involves a variety of analytical methods that can qualitatively or quantitatively determine the inorganic and elemental composition of solids, liquids, aqueous solutions, chemical mixtures, materials, or products. Inorganic components include cations, metals, anions, and inorganic salts. The inorganic impurities or elements do not provide any therapeutic benefit to humans and can also compromise the safety, efficacy, and quality of pharmaceutical products.
For instance, according to the study report published by Analytical Letters Taylor & Francis in May 2021, patients with chronic kidney disease (CKD) have compromised kidney function, which affects impurity excretion. These impurities in medications were analyzed using HR–CS GFAAS, and all the products contained Cd, Cu, and Mo within the maximum allowed limits. Hence, inorganic elemental analysis plays a major role in the industry’s drug manufacturing, which will drive the growth of the segment over the study period.
Also, according to the study report published by Biological Trace Element Research in September 2021, the circulatory levels of trace elements were analyzed using inductively coupled plasma mass spectrometry (ICP-MS) and it was found that levels of Al, Mn, Co, Ni, Cu, As, Se, Sr, and Pb were higher, while levels of Cr, Zn, Rb, Cd, and U were lower in hemodialysis patients. Hence, inorganic elemental analysis plays a major role in clinical settings, which can rule out the elemental levels in the bloodstream.
Thus, inorganic elemental analysis in industrial and clinical settings significantly drives the segment’s growth in the study period.
North America Dominates the Global Elemental Analysis Market During the Forecast Period
North America is expected to dominate the global elemental analysis market owing to the vast development of technologically advanced products for elemental analysis and the availability of extensive areas of elemental analysis applications such as healthcare, pharmaceuticals, biotechnology, chemicals, and the food and beverage industries, among others.
The essential elements are severely altered in chronic kidney disease (CKD) patients with decreased levels of micronutrients such as zinc, selenium, iron, and calcium. Hence, with the rise in CKD cases, the demand for diagnosing the elements in the bloodstream increases, thereby having a significant impact on the elemental analysis market.
For instance, as per the CDC report, in 2021, 15% of United States adults, or 37 million people, are estimated to have CKD. As a result, the significant number of CKD cases increases the demand for elemental analysis, as CKD is associated with changes in trace elements in the bloodstream. Also, new product approvals and launches help the market grow in this region. For instance, in October 2020, Analytik Jena launched its new version of the ASpectMS operating software for Analytik Jena’s PlasmaQuant MS series ICP-MS systems. The updated version also contains 21 CFR Part 11 compliance, improvements to user assistance, report functionality, and optimizations for plasma performance when using organic materials.
Hence, owing to the above-mentioned factors, the North American region is expected to witness high growth over the forecast period.
Elemental Analysis Market Competitor Analysis
The elemental analysis market is moderately competitive due to the presence of several companies operating globally. The major players include Thermo Fisher Scientific, Inc., PerkinElmer Inc., Shimadzu Corporation, Analytik Jena GmbH+Co. KG, Agilent Technologies, Inc., Elemental Analysis, Inc., Rigaku Corporation, Eurofins Scientific, Bruker, HORIBA, Ltd., Angstrom Advanced, Inc., and Verder Scientific GmbH & Co. KG (ELTRA GmbH). The players operating in the market focus on introducing new products to address the changing needs of patients.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing R&D Funding in Life Sciences
4.2.2 Mandating Government Regulations for Elemental Analysis of Pharmaceutical and Healthcare Products
4.3 Market Restraints
4.3.1 Lack of Skilled Personnel
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Type
5.1.1 Organic Elemental Analysis
5.1.2 Inorganic Elemental Analysis
5.2 By Technology
5.2.1 Destructive Technologies
5.2.1.1 Inductively Coupled Plasma-Atomic Emission Spectroscopy (ICP-AES)
5.2.1.2 Inductively Coupled Plasma-Mass Spectroscopy (ICP-MS)
5.2.1.3 Combustion Analysis
5.2.1.4 Others
5.2.2 Nondestructive Technologies
5.2.2.1 X-Ray Fluorescence Spectroscopy (XRF)
5.2.2.2 Fourier Transform Infrared Spectroscopy (FTIR)
5.2.2.3 Others
5.3 By End User
5.3.1 Pharmaceutical and Biotechnology Companies
5.3.2 Research Organizations
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Thermo Fisher Scientific, Inc.
6.1.2 PerkinElmer, Inc.
6.1.3 Shimadzu Corporation
6.1.4 Analytik Jena GmbH+Co. KG
6.1.5 Agilent Technologies, Inc.
6.1.6 Elemental Analysis, Inc.
6.1.7 Rigaku Corporation
6.1.8 Eurofins Scientific
6.1.9 Bruker
6.1.10 Verder Scientific GmbH & Co. KG (ELTRA GmbH)
6.1.11 Angstrom Advanced Inc.
6.1.12 HORIBA, Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS